Pacific Health Care Organization (PFHO)
(Delayed Data from OTC)
$0.85 USD
0.00 (0.00%)
Updated Sep 19, 2024 02:13 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Pacific Health Care Organization Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6 | 6 | 5 | 6 | 7 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 6 | 6 | 5 | 6 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 5 | 5 | 5 | 5 | 6 |
Income After Depreciation & Amortization | 1 | 1 | 1 | 1 | 2 |
Non-Operating Income | 0 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 1 | 1 | 1 | 1 | 2 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1 | 0 | 1 | 1 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1 | 0 | 1 | 1 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1 | 1 | 1 | 1 | 2 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 1 | 1 | 1 | 1 | 2 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 12.82 | 12.82 | 12.82 | 12.82 | 12.82 |
Diluted EPS Before Non-Recurring Items | 0.06 | 0.04 | 0.08 | 0.04 | 0.09 |
Diluted Net EPS (GAAP) | 0.06 | 0.04 | 0.08 | 0.04 | 0.09 |
Fiscal Year end for Pacific Health Care Organization Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1.57 | 1.40 | 1.64 | 1.38 | 1.30 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 1.57 | 1.40 | 1.64 | 1.38 | 1.30 |
SG&A, R&D, and Dept/Amort Expenses | 1.38 | 1.22 | 1.34 | 1.23 | 1.15 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.19 | 0.18 | 0.30 | 0.15 | 0.15 |
Non-Operating Income | 0.11 | 0.10 | 0.11 | 0.10 | 0.10 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 0.30 | 0.27 | 0.41 | 0.25 | 0.25 |
Income Taxes | 0.08 | 0.08 | 0.13 | 0.07 | 0.07 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 0.22 | 0.20 | 0.28 | 0.18 | 0.18 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 0.22 | 0.20 | 0.28 | 0.18 | 0.18 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 12.82 | 12.82 | 12.80 | 12.82 | 12.82 |
Diluted EPS Before Non-Recurring Items | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
Diluted Net EPS (GAAP) | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 |